Immune regulation by new NK receptor family molecules
Immune regulation by new NK receptor family molecules
批准号:
16390141
负责人:
ARASE Hisashi
金额:
$9.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
NK cell receptors consist of activating and inhibitory receptors. These receptors seem to have been evolved with pathogens such as viruses and seem to play an important role in host defense. In the present study, we have tried to elucidate the mechanism of immune regulation by NK cells through identification of new activating NK receptors and its ligands. We have identified activating PILR and CD200 receptors as DAP12 associating receptors from cDNA library of NK cells (Shiratori et al. J.Immunol. 2005). Furthermore, we have cloned the ligand for PILR and showed that PILR ligand play an important role for the target cell recognition by NK cells (Shiratori et al. J.Exp.Med. 2004). In addition, we have found that B16 melanoma is recognized by PILR although B16 does not express PILR-ligand. Therefore, we generated cDNA library from B16 melanoma and did expression cloning. We have cloned PILR-L2 as a ligand for PILR. Indeed, PILR-L2 expressing cells were recognized by PILR expressing cells. From these observations, PILR was found to play an important role in the target cell recognition by NK cells. Furthermore, we have found that glycosylation is involved in the ligand recognition by PILR. When certain glycosyltransferase was transfected to B16, PILR ligand exressed on B16 was not recognized by PILR anymore. PILR ligand expressed on B16 transfectants was not recognized by inhibitory PILR expressed on macrophage and B16 transfectants activated macrophage very well. Therefore, certain tumor cells seemed to have acquired the ligand for inhibitory PILR by modification of the structure of glycosylation of PILR ligand and seemed to suppress the response to tumor cells. These findings may provide a novel mechanism of immune evasion by tumor.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Heterotypic interaction of CRTAM with Necl2 induced cell adhesion on activated NK cells and CD8^+ T cells.
CRTAM与Necl2的异型相互作用诱导细胞粘附在活化的NK细胞和CD8+T细胞上。
DOI:
--
发表时间:
2005
期刊:
International Immunology 17・9
影响因子:
--
作者:
[Arase, N., Shiratori Ikuo, Arase Noriko]
通讯作者:
Arase Noriko
PILRαと結合するポリペプチド、およびそれをコードするポリヌクレオチド、並びにその利用
与PILRα结合的多肽、编码其的多核苷酸及其用途
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[]
通讯作者:
Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors
抑制性 NKR-P1 自然杀伤细胞受体对 Ocil/Clr-b 的自我识别缺失
DOI:
--
发表时间:
2004
期刊:
Proc.Natl.Acad.Sci.USA. 101
影响因子:
--
作者:
[Carlyle, J.R.]
通讯作者:
J.R.
NFAM1, a new ITAM^+ cell surface molecule that regulates development and signaling of B lymphocytes.
NFAM1 是一种新的 ITAM^ 细胞表面分子,可调节 B 淋巴细胞的发育和信号传导。
DOI:
--
发表时间:
2004
期刊:
Proc.Natl.Acad.Sci.USA. 101
影响因子:
--
作者:
[Ohtsuka, M.]
通讯作者:
M.
FcεRIγ-ITAM is differentially required for mast cell function in vivo.
FcεRIγ-ITAM 对体内肥大细胞功能的需求存在差异。
DOI:
--
发表时间:
2004
期刊:
J Immunol 172巻4号
影响因子:
--
作者:
[Sakurai D, Yamasaki S, Arase K, Park SY, Arase H, Konno A, Saito T.]
通讯作者:
Saito T.
共 13 条
Mechanism of misfolded protein transportation to outside cells
-
批准号:25670143
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:ARASE Hisashi
-
依托单位:
Analysis of function of misfolded proteins presented on MHC class II molecules.
-
批准号:24659223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:ARASE Hisashi
-
依托单位:
Mechanism of herpesvirus infection
-
批准号:23390112
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.65万
-
财政年份:2011
-
负责人:ARASE Hisashi
-
依托单位:
Study on immune evasion mechanism by Staphylococcus aureus via immune inhibitory receptors
-
批准号:23659223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2011
-
负责人:ARASE Hisashi
-
依托单位:
New immune regulatory mechanism by paired receptors
-
批准号:20390143
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:ARASE Hisashi
-
依托单位:
Elucidation of novel immune regulatory mechanism by PILR that belongs to NK cell receptor family.
-
批准号:18390151
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.77万
-
财政年份:2006
-
负责人:ARASE Hisashi
-
依托单位:
Mechanism of immune-surveillance and immune-regulation by paired receptors
-
批准号:16043210
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$25.34万
-
财政年份:2003
-
负责人:ARASE Hisashi
-
依托单位:
Analysis of signaling molecules for NK cell receptors
-
批准号:09670328
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:ARASE Hisashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PILR-α阻断PD-1/PD-L1轴促进肿瘤微环境免疫T细胞浸润治疗肺腺癌的机制研究
-
批准号:2023JJ30980
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:周东波
-
依托单位:
长链非编码RNA-PILR充当p53-Parkin分子脚手架调控糖尿病心肌病线粒体自噬的机制研究
-
批准号:81900339
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:侯君
-
依托单位:
PILRα通过下调β2整合素活化抑制肾脏纤维化的调节作用和分子机制研究
-
批准号:81700587
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:杜邱娜
-
依托单位:
转录激活因子PilR在σ54调控水稻白叶枯病菌毒性中的功能研究
-
批准号:31600105
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2016
-
负责人:余超
-
依托单位: